HORMONAL IMBALANCES AND THEIR ASSOCIATION TO PCOS AND UTERINE FIBROIDS IN YOUNG PAKISTANI WOMEN
Main Article Content
Keywords
Hormonal imbalance, PCOS, uterine fibroids, young women, reproductive health, Pakistan.
Abstract
Objective: This study aimed to investigate the relationship between hormonal imbalances, Polycystic Ovary Syndrome (PCOS), and uterine fibroids in young Pakistani women aged 18 to 35 years.
Methods: A cross-sectional observational study was conducted with 330 female patients presenting symptoms of hormonal imbalances. Data collection involved structured interviews, standardized questionnaires, clinical assessments, hormonal profiling, ultrasound imaging, and Body Mass Index (BMI) calculation. Descriptive statistics, correlation, and multiple logistic regression analyses were used to identify the association between hormonal imbalances and reproductive conditions.
Results: Among the 330 participants, 57.6% were diagnosed with PCOS and 27.3% with uterine fibroids. PCOS patients showed elevated androgen levels (60 ng/dL) and insulin resistance (65%), while fibroid patients exhibited high estrogen levels (350 pg/mL) and low progesterone levels (4 ng/mL). Metabolic disturbances, including insulin resistance and abnormal lipid profiles, were more prevalent in the PCOS group. Additionally, psychological impacts such as depression and anxiety were reported by 50% of PCOS patients and 35% of fibroid patients.
Conclusion: Hormonal imbalances, particularly elevated androgens and estrogen, significantly contribute to the development of PCOS and uterine fibroids in young Pakistani women. Early detection and comprehensive management are essential to prevent long-term reproductive and metabolic complications.
References
2. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for assessing and managing polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–18.
3. Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–55.
4. Nisar N, Sohoo NA. Frequency of polycystic ovary syndrome (PCOS) and its associated risk factors among female medical students of a public sector university in Pakistan. J Ayub Med Coll Abbottabad. 2019;31(4):602–6.
5. Asim M, Nawaz M, Iftikhar A, et al. Lifestyle risk factors associated with PCOS among undergraduate students in Lahore. J Pak Med Assoc. 2020;70(5):843–7.
6. Kausar S, Gull S, Haider J, et al. Polycystic ovary syndrome and its association with body mass index among adolescent girls in Pakistan. Rawal Med J. 2021;46(3):670–4.
7. Ahmed K, Javed A, Farooq N. Prevalence of PCOS in young women and its association with BMI and lifestyle factors in urban Pakistan. Pak J Med Health Sci. 2020;14(4):692–6.
8. Jabeen R, Rehman R, Mehmood K, et al. The psychological impact of polycystic ovary syndrome on adolescent girls in Pakistan. Cureus. 2021;13(7):e16310.
9. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565–92. doi:10.1210/jc.2013-2350.
10. Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321–36. doi:10.1097/AOG.0000000000002698.
11. Zhu J, Chan YM. Fertility issues for patients with hypogonadotropic causes of delayed puberty. Endocrinol Metab Clin North Am. 2015;44:821–34. doi:10.1016/j.ecl.2015.07.009.
12. Chen YH, Heneidi S, Lee JM, Layman LC, Stepp DW, Gamboa GM, et al. MiRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 2013;62:2278–86. doi:10.2337/db12-0963.
13. Ifeanyi OE, Uzoma OG. A review on fibroid and heptoglobin. Int J Curr Res Med Sci. 2018;4(8):1–8.
14. Borahay MA, Asoglu MR, Mas A. Estrogen receptors and signaling in fibroids: Role in pathobiology and therapeutic implications. Reprod Sci. 2017;24:1235–44. doi:10.1177/1933719117698575.
15. Obeagu EI, Njar VE, Obeagu GU. Infertility: Prevalence and consequences. Int J Curr Res Chem Pharm Sci. 2023;10(7):43–50.
16. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: A systematic review. BJOG. 2017;124:1501–12. doi:10.1111/1471-0528.14640.
17. Jakimiuk A, Nowicka M, Bogusiewicz M. Prevalence of estrogen receptor alpha PvuII and XbaI polymorphism in the population of Polish postmenopausal women. Folia Histochem Cytobiol. 2017;45:331–8. doi:10.5603/FHC.2017.0045.
18. Wallach EE, Vlahos NF. Uterine myomas: An overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393–406. doi:10.1097/01.AOG.0000136079.62513.39.
19. Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19(8):519–27. doi:10.1093/molehr/gat024.
20. Mihm M, Gangooly S, Muttukrishna S. The normal menstrual cycle in women. Anim Reprod Sci. 2011;124(3–4):229–36. doi:10.1016/j.anireprosci.2010.08.030.